Do remotely think that a new unfounded therapy with manufactured cells being IPSC's are going to be passed anytime soon, over what the FDA can't already get their head around that is being used throughout the world?
1. They’re not “unfounded.”
2. Your sentence makes no sense (big night on the bottle again?).
3. There are good reasons why tissue-derived MSCs are running into issues with the FDA. This is all out in the public domain.
4. Question for you: How long transpired between Cynata submitting an application to run a P2 trial in GvHD and it being accepted by the FDA?
Ann: Investor Presentation, page-191
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |